Healthy Volunteers Clinical Trial
Official title:
Collection of Blood, Bone Marrow, Skin Biopsies and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols Laboratory Research Studies
Background:
- Laboratory research studies require control samples from healthy volunteers to compare with
samples from patients. These studies will help researchers better understand and refine
treatments for immune system and inflammatory diseases.
Objective:
- To obtain blood, urine, buccal (mouth) mucosa, normal tissue and bone marrow samples and/or
leukopheresis cells from healthy volunteers.
Eligibility:
- Healthy individuals at least 8 years of age.
Design:
- Volunteers will be recruited through the Program for Healthy Volunteers, Patient
Recruitment and Public Liaison Office, or self-referral through the clinicaltrials.gov
Web site.
- Health will be confirmed by a brief history and physical examination and blood work.
- Volunteers 8 years of age and older will provide blood and urine samples using standard
procedures. Buccal mucosa samples will be obtained by scraping the insides of both
cheeks with a sterile nylon brush.
- Bone marrow samples will be obtained from volunteers 18 years of age and older by taking
two aspirates from the posterior iliac crest (an area near the hip).
- Normal tissue samples will be obtained from volunteers 18 years of age and older by
taking superficial skin samples (punch biopsies)
- Leukopheresis or lymphapheresis will be performed on volunteers 18 years of age and
older to obtain white blood cells for research
- Samples will be assigned a unique code and will be stored until they are no longer of
scientific value or the volunteer withdraws consent for their use.
The purpose of this protocol is to collect blood (ages 8 and older), urine (ages 8 and
older), buccal mucosa samples (ages 8 and older), normal tissue (ages18 and older) bone
marrow (ages 18 and older) and/or leukapheresis cells (ages 18 and older) from healthy
volunteers, including pregnant women (ages 18 and older, blood and/or buccal mucosa only). To
be enrolled on this study, pregnant women must not carry the diagnosis of an immune-mediated
or inflammatory disease, or have signs or symptoms of an immune or inflammatory disease;
otherwise they may be eligible for participation on CHI protocol 10-H-0162 in the affected
adult cohort. Samples will be used as controls for clinical and translational research in the
Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI). These control
samples are indispensable for many of our laboratory research projects, including
understanding the pathophysiology of a wide variety of immune-mediated and inflammatory
diseases.
The primary objective is to provide a mechanism for collection, tracking, storing,
dispensing, analyzing and disposing of these laboratory research samples from healthy
volunteers.
There is no primary endpoint.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT06236009 -
A First-In-Human Study of TAK-004 in Healthy Adults
|
Phase 1 |